Julia S. Anixt, MD

Director, The Kelly O'Leary Center for Autism Spectrum Disorders

Pediatrician, Division of Developmental and Behavioral Pediatrics

Academic Affiliations

Associate Professor, UC Department of Pediatrics

Phone 513-636-4611

Fax 513-636-3800

Email julia.anixt@cchmc.org


Autism spectrum disorders (ASD); attention deficit / hyperactivity disorder (ADHD); developmental outcomes in children with congenital heart disease (CHD); medication management of ADHD in children with CHD.


Interventions to improve care and outcomes for children with ASD, including Shared Decision Making; developmental outcomes in children with CHD; use and safety of stimulant medication to treat ADHD in children with CHD.

Julia Anixt, MD, is a developmental-behavioral pediatrician whose research focuses on medication decision making for the treatment of behavioral conditions in children. Her goal is to optimize the quality of life and daily functioning of individuals with developmental and behavioral conditions, including autism spectrum disorder (ASD) and attention deficit / hyperactivity disorder (ADHD), by aligning the prescribing of behavioral medication treatments to best fit patient / family preferences, values and priorities through the use of shared decision making. She has expertise in the evaluation and treatment of children with developmental and behavioral conditions associated with complex congenital heart disease (CHD) and is engaged in research studies to better understand the developmental needs of this population and assess the risks and benefits of behavioral medication use.

Dr. Anixt has a unique combination of clinical expertise, research, and QI skills and serves as an advisor to two learning networks. She is an improvement advisor for the Autism Treatment Network (ATN) learning network. Additionally, she is leading a developmental screening initiative to detect delays and improve referrals to early intervention services for infants with complex CHD, at more than 55 centers through the National Pediatric Cardiology Quality Improvement Collaborative.

BS : Haverford College, Haverford, PA, 1996.

MD: University of Maryland School of Medicine, Baltimore, MD, 2001.

Residency: Pediatrics, Yale New-Haven Hospital, New Haven, CT, 2004.

Fellowship: Robert Wood Johnson Clinical Scholars Program, Johns Hopkins University, Baltimore, MD, 2006; Developmental-Behavioral Pediatrics, University of Maryland, Baltimore, MD, 2008.

Certification: General Pediatrics, American Board of Pediatrics, 2004; Developmental and Behavioral Pediatrics, American Board of Pediatrics, 2011.

View PubMed Publications

Tamm L, Denton CA, Epstein JN, Schatschneider C, Taylor H, Arnold LE, Bukstein O, Anixt J, Koshy A, Newman NC, Maltinsky J, Brinson P, Loren REA, Prasad MR, Ewing-Cobbs L, Vaughn A. Comparing treatments for children with ADHD and word reading difficulties: A randomized clinical trial. J Consult Clin Psychol. 2017 May;85(5):434-446.

Goldenberg PC, Adler BJ, Parrott A, Anixt J, Mason K, Phillips J, Cooper DS, Ware SM, Marino BS. High burden of genetic conditions diagnosed in a cardiac neurodevelopmental clinic. Cardiol Young. 2017 Apr;27(3):459-466. 

Anixt JS, Vaughn AJ, Powe NR, Lipkin PH. Adolescent Perceptions of Outgrowing Childhood Attention-Deficit Hyperactivity Disorder: Relationship to Symptoms and Quality of Life. J Dev Behav Pediatr. 2016 Apr;37(3):196-204.

Alsaied T, Marino BS, Esbensen AJ, Anixt JS, Epstein JN, Cnota JF. Does Congenital Heart Disease Affect Neurodevelopmental Outcomes in Children With Down Syndrome? Congenital Heart Disease. 2016;11(1): 26-33.

Connolly N, Anixt J, Manning P, Ping-I Lin D, Marsolo KA, Bowers K. Maternal metabolic risk factors for autism spectrum disorder-An analysis of electronic medical records and linked birth data. Autism Res. 2016 Aug;9(8):829-37.

Lipstein EA, Lindly OJ, Anixt JS, Britto MT, Zuckerman KE. Shared Decision Making in the Care of Children with Developmental Behavioral Disorders. Maternal and Child Health Journal. 2016;20(3): 665-73.

Downes A, Anixt JS, Esbensen A, Wiley S, Meinzen-Derr J. Psychotropic Medication Use in Children and Adolescents with Down Syndrome. Journal of Developmental & Behavioral Pediatrics. 2015;36(8): 613-19.

Froehlich TE, Delgado SV, Anixt JS. Expanding Medication Options for Pediatric ADHD. Current Psychiatry. 2013 Dec;12(12):20-9.

Anixt JS, Copeland-Linder N, Haynie D, Cheng TL. Burden of Unmet Mental Health Needs in Assault-Injured Youths Presenting to the Emergency Department. Acad Pediatr. 2012 Mar-Apr;12(2):125-30.

Froehlich TE, Anixt JS, Loe IM, Chirdkiatgumchai V, Kuan L, Gilman RC. Update on Environmental Risk Factors for Attention-Deficit/Hyperactivity Disorder. Curr Psychiatry Rep. 2011 Oct;13(5):333-44.